Navigation Links
NeoStem Announces Change in Presentation Time for JMP Securities Conference
Date:9/27/2011

NEW YORK, Sept. 27, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced a change in the scheduling of its previously announced presentation at the 6th Annual JMP Securities Healthcare Conference. Dr. Robin L. Smith, Chairman and CEO of NeoStem, and Dr. Andrew L. Pecora, Chief Medical Officer of NeoStem, will now present on Tuesday, September 27th at 3:30 PM. The event takes place at the St. Regis Hotel in New York City at 2 East 55th Street.

About NeoStem, Inc.NeoStem is engaged in the development and manufacturing of cell-based therapies in the U.S. Its January, 2011 acquisition of Progenitor Cell Therapy, and its July 13, 2011 agreement to acquire Amorcyte, Inc. (which is expected to close in the fourth quarter subject to shareholder approval) position NeoStem to achieve its mission of capturing the paradigm shift to cell therapy.

PCT not only gives NeoStem access to a world class contract manufacturing cell therapy company, but provides NeoStem a platform and expertise around the evaluation, development and regulatory requirements necessary to develop autologous, allogeneic, immunomodulatory and vaccine-based therapeutics.

NeoStem also holds the worldwide exclusive license to VSEL™ Technology, which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. NeoStem owns 80% of Athelos Corporation, a company developing a T-cell therapeutic with potential in a range of auto-immune conditions such as graft versus host disease, asthma and diabetes. NeoStem's acquisition of Amorcyte, once the transaction is completed, will give the Company a Phase II asset for the
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeoStem Announces Participation in Multiple September Conferences
2. NeoStem Appoints Grant Thornton LLP as New Independent Registered Public Accounting Firm
3. NeoStem Provides Update on Amorcyte Clinical Progress and Reports Results for Second Quarter
4. NeoStem Announces Pricing of Public Offering for $16,500,000 in Gross Proceeds
5. NeoStem Announces Proposed Public Offering of Common Stock
6. NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
7. NeoStem Announces Agreement with Nankai Hospital in Tianjin to Offer NeoStems Licensed Orthopedic Technology
8. NeoStems Suzhou Erye Pharmaceutical Receives Two Awards at the Chempharm Brand Summit 2011
9. NeoStems Subsidiary Progenitor Cell Therapy Receives FACT Accreditation for Its New Allendale, New Jersey Manufacturing Facility
10. NeoStem to Present at 10th Annual Needham Healthcare Conference on Tuesday, April 5
11. NeoStem Provides Results for 2010 and an Update on Recent Activities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2014)... 2014 /PRNewswire-iReach/ -- This is a professional ... Chinese Vardenafil (CAS 224785-90-4) industry. The report ... (CAS 224785-90-4) including its classification, application and ... and China,s top manufacturers of Vardenafil (CAS ... value, cost, gross margin and market share ...
(Date:7/25/2014)... "Australia Capsule Endoscopy Systems Market Outlook to 2020″, provides ... market. The report provides value, in millions of US ... dollars) within market segments: Photo - ... , Capsule Endoscopy Data Recorders , Capsule Endoscopy ... shares and distribution shares data for each of these ...
(Date:7/25/2014)... Kan. , July 25, 2014 /PRNewswire-iReach/ -- ... and TCGRx, of Powers Lake, Wisconsin ... partners in a distribution and co-marketing agreement allowing ... retail pharmacies throughout the United States ... robotics-based pharmacy management and workflow systems to retail ...
Breaking Medicine Technology:Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts 2Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts 3Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3
... N.J., Sept. 29, 2011 Innophos Holdings, Inc. (NASDAQ: ... had declared a third quarter dividend of $0.25 per share ... 31, 2011 to stockholders of record as of the close ... Innophos Holdings, Inc.Innophos is the leading North American producer of ...
... Calif., Sept. 29, 2011 Meg Porfido, former chief ... named to the Board of Directors for Kaiser Foundation ... "The addition of Meg Porfido to our Board will ... our Board of Directors," said George C. Halvorson, chairman ...
Cached Medicine Technology:Kaiser Foundation Hospitals and Health Plan Appoints Meg Porfido to Its Board of Directors 2Kaiser Foundation Hospitals and Health Plan Appoints Meg Porfido to Its Board of Directors 3
(Date:7/28/2014)... The American Society of ... engaged in the field of organ transplantation, today ... Immunology Research Network (TIRN), a professional network ... modern organ transplantation continues to diversify, AST determined ... more opportunities for physicians, scientists and researchers to ...
(Date:7/28/2014)... Research into improving treatment for patients with one of ... 810,000 funding boost. , Chronic obstructive pulmonary disease (COPD) ... cause breathing difficulties due to long-term damage to the ... for 10 per cent of all hospital admissions in ... readmitted to hospital after they are discharged. ...
(Date:7/28/2014)... Malibu, CA (PRWEB) July 28, 2014 ... upon us, it is welcome news that a ... effective than current protection is under development by SunSeeker ... by NASA to protect spacecraft from the extreme heat ... protection to both firefighters and homes. , “Our firefighters ...
(Date:7/28/2014)... 28, 2014 Drorit Silverman, a professional ... plans to raise investment capital through her crowd funding ... in the United States. , According to a statement ... fitness centers provide a great window of opportunity for ... space. In addition to this, Silverman looks at the ...
(Date:7/28/2014)... (Boston)-- Researchers from Boston University School of Medicine (BUSM) ... increase the risk of developing Alzheimer,s disease (AD). The ... new drug treatment options that target PLXNA4 specifically. These ... , AD is the most frequent age-related dementia affecting ... 65 and older, and more than 40 percent of ...
Breaking Medicine News(10 mins):Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 2Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 3Health News:New research to tackle treatment for lung disease 2Health News:New research to tackle treatment for lung disease 3Health News:Revolutionary Fire Blanket Offers Over 200 Percent More Fire Protection to Firefighters and Homes 2Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:Researchers identify potential biomarker for AD 2
... and Treatment Centers Seek Competitive Advantage by Leveraging ... to make ends meet, the ability to do ... gain efficiencies comes from two converging market forces: ... recession-proof healthcare industry, and the national push to ...
... will be made available closer to the meeting date. ... the meeting as well as during the meeting. , ... Council of the National Academy of Sciences. The Society,s ... and to encourage applications of research findings. Its membership ...
... QC, April 2 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... the results of its recently completed North American ... of tramadol and acetaminophen (study 06CCL3-001). , Study ... that compared the efficacy and safety of Labopharm,s ...
... connect, exchange information and ,speak, HL7. , ... Toronto, ... - a core need in modern healthcare - has never been ... HL7 Interface Engine . This easy-to-use yet powerful tool, ...
... through common symptoms during pregnancy, such as morning sickness, fatigue and weight ... when they come. At Gurgle, we offer a guide to women in ... , ... London, England (PRWEB) April 2, 2009 -- Around half of ...
... NY -- Biomedical informatics researchers at Mayo Clinic ... the newly founded Open Health Natural Language Processing ... space to promote past and current development efforts, ... records. , As part of the launch, Mayo ...
Cached Medicine News:Health News:Hospitals Turn to Vendors Like Elekta for Help in Squeezing Most From Existing Technologies 2Health News:Hospitals Turn to Vendors Like Elekta for Help in Squeezing Most From Existing Technologies 3Health News:Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation 2Health News:Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation 3Health News:Talking Iguana - Helping the Healthcare Sector Speak HL7 2Health News:Talking Iguana - Helping the Healthcare Sector Speak HL7 3Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 2Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 3Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 4Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 5Health News:Mayo Clinic and IBM host medical language initiative 2Health News:Mayo Clinic and IBM host medical language initiative 3Health News:Mayo Clinic and IBM host medical language initiative 4
Outer diameter 8.0 mm, with graduation....
Greenberg micro instrument holder is a flexbar arm used to hold micro instruments used repeatedly within retracted fields. Holds instruments with shafts up to 1/8 in diameter....
Greenberg universal retractor case, with four compartments to hold various components....
Length-9 (229 mm) Tapered retractor blades....
Medicine Products: